IL6 and Alzheimer disease: In close accordance with a previous study [12], topical application of DBT significantly inhibited the expression of AD-related pathogenic cytokines such as IL-4, IL-6, IFN-γ, TNF-α, and IL-1β regardless of Th1 and Th2 cytokines similarly to DEX group.